Navigation Links
Chimerix's Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study
Date:7/23/2012

RESEARCH TRIANGLE PARK, N.C., July 23, 2012 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced the presentation of data showing that its lead antiviral compound, CMX001, has the potential to reduce end-organ damage associated with BK virus (BKV) in hematopoietic stem cell transplant (HSCT) recipients.  This new retrospective analysis, entitled "CMX001, a Novel Broad Spectrum Antiviral, May Mitigate Signs of BK Virus (BKV) Associated Bladder and Kidney End-Organ Damage," was presented at the 24th International Congress of the Transplantation Society in Berlin, Germany.

BKV infection is commonly observed post solid organ transplant (SOT) and is associated with renal dysfunction and potential kidney graft loss.  BKV is also known to cause hemorrhagic cystitis (a painful inflammatory bladder condition) in HSCT recipients, but the incidence and impact of BKV infection on bladder or kidney dysfunction in this patient population have been less well characterized.  Herve Mommeja-Marin, MD, Vice President of Clinical Research at Chimerix, presented the BKV data from the Phase 2 Study CMX001-201, which had as its primary objective the evaluation of CMX001 versus placebo for the prevention of cytomegalovirus (CMV) infection in 230 HSCT recipients.  Phase 2 results presented elsewhere have shown that CMX001, at various doses, was active and well-tolerated in the prevention of CMV infection or disease.   

The observations from Study 201 represent the largest retrospective analysis of BKV-associated signs and symptoms collected in a randomized, placebo-controlled trial reported to date.  In Study 201, which evaluated only HSCT recipients, there was a high incidence of BKV infection: BKV was measurable in the urine samples of 55% (126/230) of subjects at some time during the study period.  Of these subjects, 80% (101/126) were positive
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. The Biomedical Device Industry in America: Challenges at Home and Abroad
2. Polish Medicine Attracts Patients From Abroad - Not Only During EURO 2012
3. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
4. Broad Patent Protection Granted for iBio Immunomodulator
5. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
6. Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth
7. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
8. Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of Pol I as New Approach to Cancer Therapy
9. LIVE VIA SATELLITE: Physician Demonstrates New Medical Technology to Combat Back Pain without Major Surgery
10. Six-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib
11. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015 Today, the California ... a state prescription database before prescribing the most addictive ... of overdose deaths. SB 482, authored by ... , will require prescribers to check the Controlled ... Schedule II and III drugs, like OxyContin and other ...
(Date:5/28/2015)... 27, 2015 Research and Markets( http://www.researchandmarkets.com/research/324sfl/global_biomedical ... "Global Biomedical Metal Market 2015-2019" report to ... market to grow at a CAGR of 7.27% ... being used for a number of applications in ... stainless steel, titanium-based alloys, cobalt-based alloys, nitinol, magnesium ...
(Date:5/28/2015)... , May 28, 2015 A ... - Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, ... $3.6 billion by 2020. The secondary syphilis testing would ... Latin America , Middle ... (LAMEA) market accounted for about 43% revenue share of ...
Breaking Medicine Technology:California Senate Approves Legislation Requiring Physicians To Check State Database Before Prescribing Powerful, Addictive Medications, Says Consumer Watchdog 2Global Biomedical Metal Market 2015-2019 with Biomet, Dentsply, Invibio & Wright Medical Group Dominating 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 2Global Syphilis Testing Market is Expected to Reach $3.6 Billion, by 2020 - Allied Market Research 3
... JERUSALEM, November 4 Oramed Pharmaceuticals,Inc. (OTCBB: ... proprietary,drug delivery systems, announced today that its ... Concept Pharmacodynamic Study in,Dogs," has been accepted ... Annual Meeting in Bethesda, Maryland between November,13-15, ...
... GeneXpert(R) System ... ... today announced the U.S. Food & Drug Administration (FDA) categorized,Cepheid,s ... Clinical Laboratory Improvement Amendments (CLIA).,The new test is designed for ...
Cached Medicine Technology:Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Society's Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland) 2Oramed Pharmaceuticals Chosen to Present Results of GLP-1 Analog Enteral Administration Study at the Diabetes Technology Society's Eighth Annual Meeting (November 13-15, 2008; Bethesda, Maryland) 3Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 2Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 3Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 4
(Date:5/28/2015)... (PRWEB) May 28, 2015 Today the ... Data Book for the 2015 Main Residency Match®. ... and 28,906 were filled when the matching algorithm was ... 1,129 filled during the Match Week Supplemental Offer and ... , “We are pleased with the outcome of the ...
(Date:5/28/2015)... The partners of Urgent Care of Westchester ... Alicia Almendral as their chief provider for advanced beauty ... newly opened facility’s plan to offer all of Westchester ... Dr. Almendral is a board certified physician who is ... enhancement techniques. Her areas of expertise include Botox, Dermal ...
(Date:5/28/2015)... Angeles, Calif. (PRWEB) May 28, 2015 ... its selection by ContentChecked (CNCK) as its agency ... latest health and nutrition app, SugarChecked. SugarChecked is ... to better understand the potential sugars they are ... responsible for the launch of SugarChecked, execute media ...
(Date:5/28/2015)... Falls Church, VA (PRWEB) May 28, 2015 ... Roadmap to the 351(k) Application Process, **FDAnews Webinar**, ... p.m. EDT, [http://www.fdanews.com/BiosimilarsApproval , On June ... and expertise of two leading intellectual property attorneys ... the webinar Success Strategies for Biosimilars Approval: A ...
(Date:5/28/2015)... 2015 Park Cities Pet Sitter is offering ... class starting Saturday, June 6th at 10:30am. The ... McCommas Blvd in Dallas, with a maximum of six dogs ... five weeks, with no class being held over the 4th ... , In this Intermediate-to-Advanced level class, dogs will solidify their ...
Breaking Medicine News(10 mins):Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 3Health News:Bella Diosa Med Spa Welcomes Botox Specialist to Yonkers Community 2Health News:ContentChecked Selects PMBC Group To Launch New Nutrition App SugarChecked 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 2Health News:FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015 3Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3
... 2008) The Virginia Commonwealth University School of Medicine ... from the National Institutes of Healths National Institute on ... syndrome, a disorder of the endocrine system that affects ... syndrome, or PCOS, causes hormonal imbalances leading to irregular ...
... LAKE CITY, May 12 Dynatronics,Corporation (Nasdaq: ... quarter,ended March 31, 2008 on Wednesday, May 14, ... for investors later that,day at 2:30 p.m. ET ... nine month,periods. Those interested in participating should call ...
... to expand oral health care services; awards two significant oral health ... ... As part of the Illinois,Children,s Healthcare Foundation,s (ILCHF) $20 million, five-year,initiative to ... to announce a request for proposals in the oral,health care field. The ...
... http://www.cryocath.com Toronto Stock Exchange Symbol: CYT, MONTREAL, ... in cryotherapy products to treat cardiac,arrhythmias, today announced financial ... Selected Second Quarter Financial and Operational Highlights:, ... to $10.2 million or a 37.6% ...
... MELVILLE, N.Y., May 12 Gentiva Health,Services, Inc. (Nasdaq: ... health services, announced today that it is scheduled to,present ... 21, 2008 at the 2008,Citi Investment Research Global Health ... be available to the public via a live audio ...
... Low IQ more likely the younger a child is at diagnosis, ... about 5 percent of people with multiple sclerosis are diagnosed when ... cognitive function, causing memory and attention problems, and possibly low IQ ... time of diagnosis, the more likely he or she is to ...
Cached Medicine News:Health News:NIH grant to support Translational Research Center for PCOS 2Health News:Children in Illinois to Have Healthier Smiles 2Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 2Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 3Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 4Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 5Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 6Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 7Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 8Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 9Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 10Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 11Health News:CryoCath Announces Fiscal 2008 Second Quarter Results 12Health News:Gentiva(R) Health Services to Present May 21 at 2008 Citi Investment Research Global Health Care Conference in New York 2Health News:Gentiva(R) Health Services to Present May 21 at 2008 Citi Investment Research Global Health Care Conference in New York 3Health News:Multiple Sclerosis Affects Children's Cognitive Skills 2Health News:Multiple Sclerosis Affects Children's Cognitive Skills 3
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
Medicine Products: